• 1alpha,25-hydroxyvitamin D/VDR suppresses stem-like properties of ovarian cancer cells by restraining nuclear translocation of beta-catenin
• A Dual-Center study: Can ultrasound radiomics differentiate type I and type II epithelial ovarian cancer patients with normal CA125 levels?
• A Predictive Model for Initial Platinum-Based Chemotherapy Efficacy in Patients with Postoperative Epithelial Ovarian Cancer Using Tissue-Derived Small Extracellular Vesicles
• A Rare Case of Postmenopausal Hirsutism Associated With a Serous Cystadenofibroma of the Ovary
• Acetylation model predicts prognosis of patients and affects immune microenvironment infiltration in epithelial ovarian carcinoma
• Ad-VT causes ovarian cancer A2780 cell death via mitochondrial apoptosis and autophagy pathways
• Advanced cytoreductive procedures: patient positioning and exposition maneuvers in 10 steps
• Amphiregulin Downregulates E-cadherin Expression by Activating YAP/Egr-1/Slug Signaling in SKOV3 Human Ovarian Cancer Cells
• Anti-cancer effects of nitazoxanide in epithelial ovarian cancer in-vitro and in-vivo
• Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian Cancer
• Are exercise and sitting time during chemotherapy for ovarian cancer associated with treatment-related side-effects, chemotherapy completion and survival?
• Artificial intelligence-based histopathological subtyping of high-grade serous ovarian cancer
• Autophagy-mediated ID1 turnover dictates chemo-resistant fate in ovarian cancer stem cells
• Bowel Resection Outcomes in Ovarian Cancer Cytoreductive Surgery by Surgeon Specialty
• BRCA Status Dictates Wnt Responsiveness in Epithelial Ovarian Cancer
• CACNA1H restrains chemotherapy resistance in ovarian clear cell carcinoma cells by repressing autophagy
• Cardiac Atrophy, Dysfunction, and Metabolic Impairments: A Cancer-Induced Cardiomyopathy Phenotype
• Cell-intrinsic platinum response and associated genetic and gene expression signatures in ovarian cancer cell lines and isogenic models
• Changes in the tumour microenvironment mark the transition from serous borderline tumour to low-grade serous carcinoma
• Characterization of latently infected EBV+ antibody-secreting B cells isolated from ovarian tumors and malignant ascites
• Chemerin Enhances Migration and Invasion of OC Cells via CMKLR1/RhoA/ROCK-Mediated EMT
• Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer
• COL6A3 Exosomes Promote Tumor Dissemination and Metastasis in Epithelial Ovarian Cancer
• Comparison of serum Vascular Cell Adhesion Molecule (VCAM) level among epithelial ovarian cancer patients and healthy women
• Comprehensive analysis of consensus molecular subtypes for ovarian cancer from bulk to single-cell perspectives
• Correlation of PD-L1 expression with different clinico-pathological and immunohistochemical features of ovarian surface epithelial tumors
• Corrigendum: Cinnamaldehyde suppressed EGF-induced EMT process and inhibits ovarian cancer progression through PI3K/AKT pathway
• Dachsous cadherin related 1 (DCHS1) is a novel biomarker for immune infiltration and epithelial-mesenchymal transition in endometrial cancer via pan-cancer analysis
• Deciphering tumour microenvironment and elucidating the origin of cancer cells in ovarian clear cell carcinoma
• Detection of Carcinoma-Associated Fibroblasts Derived from Mesothelial Cells via Mesothelial-to-Mesenchymal Transition in Primary Ovarian Carcinomas
• Development and feasibility of an exercise therapy intervention for older women with advanced epithelial ovarian cancer referred to neoadjuvant chemotherapy prior to possible interval debulking surgery
• Dissecting the Distinct Tumor Microenvironments of HRD and HRP Ovarian Cancer: Implications for Targeted Therapies to Overcome PARPi Resistance in HRD Tumors and Refractoriness in HRP Tumors
• Do we more often opt for conservative management of ovarian tumors after changing the Dutch national guideline on enlarged ovaries? A nationwide cohort study
• Does neoadjuvant chemotherapy reduce surgical complexity in patients with advanced-stage epithelial ovarian cancer?
• Dual Inhibition of SYK and EGFR Overcomes Chemoresistance by Inhibiting CDC6 and Blocking DNA Replication
• Efficacy and safety of an oral combination therapy of niraparib and etoposide in platinum resistant/refractory ovarian cancer: a single arm, prospective, phase II study
• Efficacy and safety of minimally invasive surgery versus open laparotomy for epithelial ovarian cancer: A systematic review and meta-analysis
• Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study
• Engineering Magnetic Extracellular Vesicles Mimetics for Enhanced Targeting Chemodynamic Therapy to Overcome Ovary Cancer
• Epithelial granuloma occurring on the staple-stump after segmentectomy for ovarian cancer lung metastasis
• ETS1 drives EGF-induced glycolytic shift and metastasis of epithelial ovarian cancer cells
• Evaluating the specific STAT3 inhibitor YHO-1701 in ovarian cancer cell lines and patient-derived cell models: efficacy, mechanisms, and therapeutic potential
• Evaluation of effects of bisphenol analogs AF, S, and F on viability, proliferation, production of selected cancer-related factors, and expression of selected transcripts in Caov-3 human ovarian epithelial cell line
• Examining the impact of age on chemotherapy completion in epithelial ovarian, fallopian tube and primary peritoneal cancer: a retrospective cohort study in Thailand
• Expression and clinical significance of CLDN7 and its immune-related cells in breast cancer
• External validation of Standardized KELIM and platinum-resistant recurrence scores in patients with advanced epithelial ovarian cancer
• Factors associated with an inconclusive result from commercial homologous recombination deficiency testing in ovarian cancer
• Fallopian Tube-Derived High-Grade Serous Cancers Influence Ovarian Production of Norepinephrine and Generate Specific Metabolomic Signatures
• G-CSF Induces Neutrophil Extracellular Traps Formation and Promotes Ovarian Cancer Peritoneal Dissemination
• Generic semi-automated radiofluorination strategy for single domain antibodies: [(18)F]FB-labelled single domain antibodies for PET imaging of fibroblast activation protein-alpha or folate receptor-alpha overexpression in cancer
• Histomorphologic analysis of ovarian tumors according to the New 2020 WHO classification of female genital tumors
• Identification of Copper Homeostasis-Related Gene Signature for Predicting Prognosis in Patients with Epithelial Ovarian Cancer
• Image analysis Uncovers associations between immune landscape, collagen structure, and neoadjuvant chemotherapy in high-grade serous ovarian carcinomas
• Impact of molecular testing on the surgical management of advanced epithelial ovarian cancer
• Improving histotyping precision: The impact of immunohistochemical algorithms on epithelial ovarian cancer classification
• Injectable Biomimetic Hydrogel Constructs for Cell-Based Menopausal Hormone Therapy with Reduced Breast Cancer Potential
• Integrated genomic/epigenomic analysis stratifies subtypes of clear cell ovarian carcinoma, highlighting their cellular origin
• ISGylation enhances double-stranded RNA-induced interferon response and NFkappaB signaling in fallopian tube epithelial cells
• Large-scale analysis to identify risk factors for ovarian cancer
• Machine learning analysis of oxidative stress-related phenotypes for specific gene screening in ovarian cancer
• MicroRNA-486-3p affects cisplatin resistance in high-grade serous ovarian cancer by regulating TMIGD2: An experimental study
• Mirvetuximab after anaphylaxis to Paclitaxel: A case report
• Mucinous Carcinoma of Ovary in a 15-Year-Old Girl, A Rare Case Report and Literature Review
• Navigating the complexities of artificial intelligence in scientific writing: a dual perspective
• Netrin signaling mediates survival of dormant epithelial ovarian cancer cells
• Niraparib as maintenance therapy in Japan: a retrospective observational study using a Japanese claims database
• Outcomes of minimal residual disease at upfront debulking surgery compared with complete cytoreduction after neoadjuvant chemotherapy
• Ovarian-adnexal reporting and data system ultrasound evaluation and pathological characteristics of ovarian collision tumor
• Overexpression of miR-200s inhibits proliferation and invasion while increasing apoptosis in murine ovarian cancer cells
• Pan-cancer analysis reveals GGPS1 plays an important role in tumorigenesis in multiple tumor types
• PARP Inhibitors in Brain Metastases from Epithelial Ovarian Cancer through a Multimodal Patient Journey: Case Reports and Literature Review
• Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trial
• Physician-reported patient involvement and treatment decisions in first-line ovarian cancer in the USA and Europe
• Poly (ADP-ribose) polymerase inhibitor therapy and mechanisms of resistance in epithelial ovarian cancer
• Polycomb Repressor Complex 1 (PRC1) in ovarian cancer: A scoping literature review
• Predicting progression-free survival in patients with epithelial ovarian cancer using an interpretable random forest model
• Preoperative neutrophil/lymphocyte ratio as prognostic factor in epithelial ovarian cancer
• Primarian fallopian tube carcinoma: Clinical and radiological keys for diagnosis
• Primary Mucinous Adenocarcinoma of the Renal Pelvis: A Case Report
• Primer on fibroblast growth factor 7 (FGF 7)
• Proteomic landscape of epithelial ovarian cancer
• Racial and sociodemographic disparities in the use of targeted therapies in advanced ovarian cancer patients with Medicare
• Real-life clinical benefit of oral metronomic cyclophosphamide administration in elderly and heavily pretreated epithelial ovarian cancer patients
• RNA-binding protein THUMPD2 inhibits proliferation and promotes metastasis in epithelial ovarian cancer
• Salidroside exerts anti-tumor effects in ovarian cancer by inhibiting STAT3/c-Myc pathway-mediated glycolysis
• Sarcopenia shortens overall survival of patients with platinum-resistant recurrent ovarian cancer: inverse probability of treatment-weighting analysis
• Secondary Cytoreductive Surgery in Relapsed Platinum-Sensitive Epithelial Ovarian Cancer: A Systematic Review of Randomized Controlled Trials
• Single-cell RNA sequencing and cell-cell communication analysis reveal tumor microenvironment associated with chemotherapy responsiveness in ovarian cancer
• Single-cell RNA sequencing reveals heterogeneity in ovarian cancer and constructs a prognostic signature for prognostic prediction and immunotherapy
• Single-cell RNA sequencing reveals that MYBL2 in malignant epithelial cells is involved in the development and progression of ovarian cancer
• Single-cell transcriptomics reveals tumor landscape in ovarian carcinosarcoma
• Synergistic antitumor effect of liposomal-based formulations of olaparib and topotecan in primary epithelial ovarian cancer cells
• Telomere length as a predictor of therapy response and survival in patients diagnosed with ovarian carcinoma
• The clinical importance of IFN-gamma and human epididymis protein 4 in Egyptian patients with epithelial ovarian cancer combined with HPV infection
• The effect of tinzaparin on biomarkers in FIGO stages III-IV ovarian cancer patients undergoing neoadjuvant chemotherapy - the TABANETOC trial: study protocol for a randomized clinical multicenter trial
• The Megacomplex protects ER-alpha from degradation by Fulvestrant in epithelial ovarian cancer
• The unveiled mosaic of intra-tumor heterogeneity in ovarian cancer through spatial transcriptomic technologies: A systematic review
• Transformer-based AI technology improves early ovarian cancer diagnosis using cfDNA methylation markers
• Use of an emulated trial to investigate the association between use of nitrogen-based bisphosphonates and risk of epithelial ovarian cancer
• Vaccination with folate receptor-alpha peptides in patients with ovarian cancer following response to platinum-based therapy: A randomized, multicenter clinical trial